华大基因：公司发布多款阿尔茨海默病血液检测产品

Core Viewpoint - The company focuses on cognitive impairment diseases, particularly Alzheimer's disease, and has launched multiple blood testing products for Alzheimer's detection, integrating genetic testing for risk assessment and diagnosis [1] Company Summary - The company has developed a multi-dimensional testing solution that includes Alzheimer's blood tests and APOE gene risk assessments, aimed at risk evaluation, differential diagnosis, and medication guidance [1] - The increasing proportion of elderly population in the country is expected to drive the demand for chronic disease management, which will further enhance the need for genetic testing in personalized chronic disease management and risk warning [1] Industry Summary - The demand for chronic disease management is on the rise due to demographic changes, particularly the aging population, which is likely to boost the growth of genetic testing services [1]